참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Iodide | HCID 5238 | — |
| 반응물 | Potassium Hydroxide | HCID 14797 | — |
| 반응물 | 4-(3-Chloropropyl)morpholine | HCID 95834 | — |
| 반응물 | 1-Hydroxynaphthalene-7-sulfonic acid | HCID 3022482 | — |
| 촉매 | Tetrabutylammonium Iodide | HCID 67553 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 8-(3-Morpholinopropoxy)naphthalene-2-sulfonic acid | HCID 86718864 | 31.9% |
반응 단계
To a solution of 8-hydroxynaphthalene-2-sulfonic acid (Intermediate 26A, 300 mg, 1.34 mmol) and pulverized KOH (300 mg, 5.35 mmol) in DMF (2.0 mL) was added 4-(3-chloropropyl)morpholine (438 mg, 2.68 mmol) and NaI (401 mg, 2.68 mmol). The resulting reaction mixture was stirred at 60° C. for 12 h. TBAI (494 mg, 1.34 mmol) was then added followed by 4-(3-chloropropyl)morpholine (438 mg, 2.68 mmol). The reaction mixture was stirred at 60° C. for an additional 12 h, then diluted with water and filtered. The filtrate was purified directly using preparative HPLC to give the title compound (150 mg, 29%). 1H NMR (DMSO-d6) δ 8.49-8.34 (m, 1H), 7.80-7.70 (m, 1H), 7.70-7.60 (m, 1H), 7.36-7.19 (m, 2H), 6.89-6.77 (1 H, m), 3.95 (br s, 2H), 3.65 (br s, 4H), 3.48-3.32 (m, 2H), 3.26-3.06 (m, 2H), 2.57-2.44 (m, 2H), 2.37-2.13 (m, 2H); MS(ESI−) m/z 350.4 (M−H)−.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09346795B2 |
|---|
| 출처 데이터셋 | uspto-grants-2016_05 |
|---|
| ORD ID | ord-cbc1b18ba2834797ad18fc97e4776306 |
|---|
| 출처 메모 | uspto-grants-2016_05 |
|---|